HURA TuHURA Biosciences, Inc./NV
Price Chart
Executive Summary
TuHURA Biosciences drew $1.7M from its $50M revolving credit facility with Parkview Holdings One LLC, the first draw under the facility that matures April 2026. The minimal initial draw relative to the $50M capacity and use for general corporate purposes suggest modest near-term cash needs, but the existence of a large undrawn facility and related-party lender (affiliate of largest stockholder) introduce lingering capital structure and conflict-of-interest considerations.
Actionable Insight
Monitor for additional draws under the facility, which would signal accelerating cash burn. The large undrawn $48.3M capacity plus the related-party lender relationship warrant close attention to future 10-Q for leverage and interest cost details. The first draw is too small to materially alter the balance sheet or cash runway outlook.
Key Facts
- On May 26, 2026, TuHURA received its first draw of $1.7M under the $50M revolving credit facility entered into with Parkview Holdings One LLC on April 21, 2026.
- The facility matures on April 21, 2031.
- Proceeds are expected to be used for general corporate purposes.
- The lender, Parkview Holdings One LLC, is an affiliate of the Company's largest stockholder (per risk factor language in the filing).
Financial Impact
First draw of $1.7M; total facility capacity is $50M. No pricing terms (interest rate, fees) or specific financial covenants disclosed in this filing.
Risk Factors
- Related-party lender (affiliate of largest stockholder) introduces potential for conflicts of interest or unfavorable terms.
- Future draws could substantially increase leverage and interest burden.
- The $1.7M draw may be insufficient to fund operations if cash burn is high, necessitating additional capital raises or more draws.
- Forward-looking statements note risk that facility may be insufficient to fund operations and development programs as anticipated.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-248640 |
| Document: 0001193125-26-248640-index-headers.html | 0001193125-26-248640 |
| Document: 0001193125-26-248640-index.html | 0001193125-26-248640 |
| Document: 0001193125-26-248640.txt | 0001193125-26-248640 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
11d ago
|
8-K
| $2.24 $1.97 | ▼ −12.28% | ▼ −9.53% | $2.05 (−8.71%) |
|
May 15, 2026
25d ago
|
8-K
| $2.55 $2.45 | ▼ −3.92% | ▼ −5.54% | $2.05 (−19.80%) |
|
Apr 22, 2026
6w ago
|
8-K
| $2.68 $2.15 | ▼ −19.96% | ▼ −20.02% | $2.05 (−23.69%) |
|
Apr 8, 2026
8w ago
|
424B5
| $1.96 $2.96 | ▼ −51.02% | ▼ −47.83% | $2.05 (−4.34%) |
|
Apr 8, 2026
8w ago
|
8-K
| $1.96 $2.96 | ▲ +51.02% | ▲ +47.83% | $2.05 (+4.34%) |
|
Apr 1, 2026
9w ago
|
8-K
| $1.62 $1.96 | ▼ −20.99% | ▼ −17.22% | $2.05 (−26.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access